Daraxonrasib in Previously Treated Advanced RAS-Mutated Pancreatic Cancer

Journal:

The New England Journal of Medicine

Published:

2026-05-07

DOI:

10.1056/nejmoa2505783

Affiliations:

16

Authors:

20

Go to article

Institutions	Authors	Share
Revolution Medicines, United States of America (USA)	5.000000	0.25
Mary Crowley Cancer Research Center, United States of America (USA)	1.000000	0.05
Miami Cancer Institute, United States of America (USA)	1.000000	0.05
UCLA Health, United States of America (USA)	1.000000	0.05
The Christ Hospital Health Network, United States of America (USA)	1.000000	0.05
Columbia University in the City of New York (CU), United States of America (USA)	1.000000	0.05
Huntsman Cancer Institute at the University of Utah (HCI), Utah, United States of America (USA)	1.000000	0.05
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)	1.000000	0.05
Dana-Farber Cancer Institute (DFCI), United States of America (USA)	1.000000	0.05
University of California, Irvine (UCI), United States of America (USA)	1.000000	0.05
The University of Texas MD Anderson Cancer Center, United States of America (USA)	1.000000	0.05
NYU Langone Health, United States of America (USA)	1.000000	0.05
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, United States of America (USA)	1.000000	0.05
Sarah Cannon Research Institute (SCRI), United States of America (USA)	1.000000	0.05
NEXT Oncology – Virginia, United States of America (USA)	1.000000	0.05
NEXT Oncology, United States of America (USA)	1.000000	0.05

Interested in Oncology and Carcinogenesis?